Nylim CND US MD CP Eq ETF-UiIQSMETF

13F holders, Q2 2025 (June 30)
3holders
1new positions
1sold out
$32.24avg. 13F price*

At the end of Q2 2025, 3 institutions reported holding Nylim CND US MD CP Eq ETF-Ui (IQSM) in their 13F filings, unchanged from Q1 2025. 1 opened new positions and 1 sold out. The largest holders were New York Life Investment Management LLC ($205.6M), Seeds Investor LLC ($2.5M) and UBS Group AG ($9K).

Company
Nylim CND US MD CP Eq ETF-Ui
Filed as
NEW YORK LIFE INVESTMENTS ET (Q2 2025)
CUSIP
45409B248
Latest filing quarter
Q2 2026

History

Number of 13F holders

02468 Q1 2024: 3Q1 2024Q2 2024: 2Q2 2024Q3 2024: 3Q3 2024Q4 2024: 3Q4 2024Q1 2025: 3Q1 2025Q2 2025: 3Q2 2025Q3 2025: 7Q3 2025Q4 2025: 6Q4 2025Q1 2026: 6Q1 2026Q2 2026: 7Q2 2026

Total Exit/New Position Q1 2025 → Q2 2025

InstitutionsTotal Value
New Positions1$9K
Exits1$725K

All 13F filers, Q1 2025 → Q2 2025: 27,861 shares bought and 186,746 shares sold, net −158,885 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 3 holders

New York Life Investment Management LLC 1.92% Reduce -2.5% 6,376,327 $205.6M
Seeds Investor LLC 0.58% Add +55.8% 77,010 $2.5M
UBS Group AG 0.00% New 286 $9K

"% of holder's portfolio" is IQSM's weight in each manager's 13F, not the share of Nylim CND US MD CP Eq ETF-Ui the manager owns.